{
    "type": "ETP",
    "ucits": false,
    "replication_method": "physical",
    "leverage": true,
    "derivatives": false,
    "swaps": false,
    "inverse": false,
    "complex_factors": [
        "Leverage",
        "Daily Rebalancing",
        "Compounding Effect"
    ],
    "classification": "complex",
    "supporting_data": "The product is a Collateralised Exchange Traded Security (ETP) that seeks to provide 2x the daily performance of JPMorgan Chase & Co. stock by physically owning the underlying shares and using margin (borrowing) to achieve leverage. There is no use of synthetic replication or swap agreements mentioned. The replication method is physical, with direct ownership of the underlying asset. However, the product employs 2x leverage, daily rebalancing, and compounding effects which significantly increase complexity. The KIID explicitly states the product is not simple and may be difficult to understand, with a highest risk rating of 7/7. The product is intended for sophisticated investors able to monitor positions daily due to the risks of leverage and compounding. There is no capital protection, and the product can lose the entire investment. No derivative instruments are used inherently in the strategy, only margin borrowing to leverage physical holdings. The PRIIPs KID and factsheet confirm no swap usage or derivative exposure beyond margin borrowing. The complexity arises primarily from the leverage factor, daily rebalancing, and compounding effects, which can cause returns over periods longer than one day to deviate significantly from the expected 2x multiple of the underlying stock's return. This leverage and the associated risks, including the need for active monitoring and the potential for magnified losses, drive the MiFID II classification as complex despite the physical replication and absence of derivatives or swaps."
}